Cargando…
Neurosteroids and Neurotrophic Factors: What Is Their Promise as Biomarkers for Major Depression and PTSD?
Even though major depressive disorder (MDD) and post-traumatic stress disorder (PTSD) are among the most prevalent and incapacitating mental illnesses in the world, their diagnosis still relies solely on the characterization of subjective symptoms (many of which are shared by multiple disorders) sel...
Autores principales: | Almeida, Felipe Borges, Barros, Helena Maria Tannhauser, Pinna, Graziano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916492/ https://www.ncbi.nlm.nih.gov/pubmed/33578758 http://dx.doi.org/10.3390/ijms22041758 |
Ejemplares similares
-
The Role of HPA Axis and Allopregnanolone on the Neurobiology of Major Depressive Disorders and PTSD
por: Almeida, Felipe Borges, et al.
Publicado: (2021) -
Biomarkers for PTSD at the Interface of the Endocannabinoid and Neurosteroid Axis
por: Pinna, Graziano
Publicado: (2018) -
The role of allopregnanolone in depressive-like behaviors: Focus on neurotrophic proteins
por: Almeida, Felipe Borges, et al.
Publicado: (2020) -
Composite contributions of cerebrospinal fluid GABAergic neurosteroids, neuropeptide Y and interleukin-6 to PTSD symptom severity in men with PTSD
por: Kim, Byung Kil, et al.
Publicado: (2020) -
PPAR and functional foods: Rationale for natural neurosteroid-based interventions for postpartum depression
por: Matrisciano, Francesco, et al.
Publicado: (2020)